Literature DB >> 31662857

Are there reliable predictive factors of nonresponse to aminosalicylates in patients with ulcerative colitis?

Javier P Gisbert1, María Chaparro1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31662857      PMCID： PMC6794694          DOI： 10.1177/2050640619861891

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN： 2050-6406            Impact factor:   4.623


× No keyword cloud information.
  9 in total

Review 1.  Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.

Authors:  L Sutherland; J K Macdonald
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

Review 2.  Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.

Authors:  L Sutherland; J K Macdonald
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

3.  Adherence of gastroenterologists to European Crohn's and Colitis Organisation consensus on ulcerative colitis: a real-life survey in Spain.

Authors:  J P Gisbert; F Gomollón; J Hinojosa; A López San Román
Journal:  J Crohns Colitis       Date:  2010-07-06       Impact factor: 9.071

4.  Development and Validation of Risk Matrices Concerning Ulcerative Colitis Outcomes-Bayesian Network Analysis.

Authors:  Fernando Magro; Cláudia Camila Dias; Francisco Portela; Mário Miranda; Samuel Fernandes; Sonia Bernardo; Paula Ministro; Paula Lago; Isadora Rosa; Inês Pita; Luis Correia; Pedro Pereira Rodrigues
Journal:  J Crohns Colitis       Date:  2019-03-30       Impact factor: 9.071

Review 5.  Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis.

Authors:  Alexander C Ford; Jean-Paul Achkar; Khurram J Khan; Sunanda V Kane; Nicholas J Talley; John K Marshall; Paul Moayyedi
Journal:  Am J Gastroenterol       Date:  2011-03-15       Impact factor: 10.864

6.  Therapeutic guidelines on ulcerative colitis: a GRADE methodology based effort of GETECCU.

Authors:  Fernando Gomollón; Santiago García-López; Beatriz Sicilia; Javier P Gisbert; Joaquín Hinojosa
Journal:  Gastroenterol Hepatol       Date:  2013-01-14       Impact factor: 2.102

Review 7.  Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares.

Authors:  P D R Higgins; D T Rubin; K Kaulback; P S Schoenfield; S V Kane
Journal:  Aliment Pharmacol Ther       Date:  2008-10-07       Impact factor: 8.171

8.  Physician Perspectives on Unresolved Issues in the Management of Ulcerative Colitis: The UC Horizons Project.

Authors:  Javier P Gisbert; Manuel Barreiro-de Acosta; María Esteve; Valle García-Sánchez; Fernando Gomollón; Jordi Guardiola; Joaquin Hinojosa; Maria-Dolores Martín Arranz; Miguel Minguez; Carlos Taxonera; Isabel Vera
Journal:  Inflamm Bowel Dis       Date:  2016-03       Impact factor: 5.325

9.  Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management.

Authors:  Marcus Harbord; Rami Eliakim; Dominik Bettenworth; Konstantinos Karmiris; Konstantinos Katsanos; Uri Kopylov; Torsten Kucharzik; Tamás Molnár; Tim Raine; Shaji Sebastian; Helena Tavares de Sousa; Axel Dignass; Franck Carbonnel
Journal:  J Crohns Colitis       Date:  2017-07-01       Impact factor: 10.020
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.